Botulinum toxin mechanisms of action.

[1]  D. Dressler,et al.  Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and Hyperhidrosis , 2002, European Neurology.

[2]  I. Gibbins,et al.  Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. , 2001, American journal of physiology. Heart and circulatory physiology.

[3]  A. Berardelli,et al.  Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia , 2000, Annals of neurology.

[4]  K. Foster,et al.  Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. , 2000, Biochemical pharmacology.

[5]  K. Shimizu,et al.  [Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles]. , 2000, Nippon Ganka Gakkai zasshi.

[6]  K. Foster,et al.  Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. , 2000, Toxicon : official journal of the International Society on Toxinology.

[7]  J. Rothwell,et al.  Electromyographic Quantification of the Paralysing Effect of Botulinum Toxin in the Sternocleidomastoid Muscle , 2000, European Neurology.

[8]  W. Maixner,et al.  Opposite modulation of capsaicin-evoked substance P release by glutamate receptors , 1999, Neurochemistry International.

[9]  M. Urban,et al.  Central mechanisms in pain. , 1999, The Medical clinics of North America.

[10]  J. Dolly,et al.  Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Berardelli,et al.  Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor , 1998, Muscle & nerve.

[12]  T. Südhof,et al.  Mechanics of membrane fusion , 1998, Nature Structural Biology.

[13]  N. Kohara,et al.  Muscle afferent block for the treatment of oromandibular dystonia , 1998, Movement disorders : official journal of the Movement Disorder Society.

[14]  C D Marsden,et al.  Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. , 1997, Brain : a journal of neurology.

[15]  A. Pastor,et al.  Dose-dependent, central effects of botulinum neurotoxin type A , 1997, Neurology.

[16]  K. Arimura,et al.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin‐A injection , 1996, Muscle & nerve.

[17]  J C Rothwell,et al.  Tonic vibration reflex and muscle afferent block in writer's cramp , 1995, Annals of Neurology.

[18]  A. Berardelli,et al.  Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. , 1995, Brain : a journal of neurology.

[19]  H. Shibasaki,et al.  Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp , 1995, Muscle & nerve.

[20]  A. Pastor,et al.  Botulinum neurotoxin alters the discharge characteristics of abducens motoneurons in the alert cat. , 1994, Journal of neurophysiology.

[21]  Thomas C. Südhof,et al.  Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 , 1993, Nature.

[22]  P. Errico,et al.  Botulinum A toxin effects on rat jaw muscle spindles. , 1993, Acta oto-laryngologica.

[23]  M. Verhage,et al.  Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. , 1992, The Journal of biological chemistry.

[24]  P. Girlanda,et al.  Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[25]  C. Shone,et al.  Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. , 1992, European journal of biochemistry.

[26]  M Swenson,et al.  Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: Acoustic, aerodynamic, and videoendoscopic findings , 1992, The Laryngoscope.

[27]  Christopher O'Brien,et al.  Motor Disturbances II , 1991 .

[28]  P. Savino,et al.  Botulinum toxin therapy. , 1991, Neurologic clinics.

[29]  Michael J. Aminoff,et al.  Neuromuscular effects distant from the site of botulinum neurotoxin injection , 1988, Neurology.

[30]  C. L. Warner,et al.  Distant effects of local injection of botulinum toxin , 1987, Muscle & nerve.

[31]  R. Tanaka,et al.  TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids , 1986, FEBS letters.

[32]  E. Buckley,et al.  Botulinum toxin for blepharospasm: single-fiber EMG studies , 1986, Neurology.

[33]  H. Wiegand,et al.  Effects of type a botulinum toxin on the cholinergic transmission at spinal renshaw cells and on the inhibitory action at ia inhibitory interneurones , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  H. Wellhöner,et al.  125I-Labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  Magnetic resonance imaging in , 2002 .

[36]  M. Hallett,et al.  24 – The pathophysiology of spasmodic dysphonia and its modification by botulinum toxin , 1990 .

[37]  J. Kerner.  Neue Beobachtungen über die in Würtemberg so häufig vorfallenden tödtlichen Vergiftungen durch den Genuß geräucherter Würste , 1820 .